top of page

Get weekly indie film market intel. Subscribe to S&R's "Below the Line" newsletter today!

AFM 2026: Buyers Are Back. But the Rules Have Changed... Again.

59 minutes ago
9 min read

Horror MGs are falling, lower-budget films are finding renewed opportunities, and larger independent packages are finally feeling the pressure. Here's what we learned from the buyers at AFM.


I came away from this year's American Film Market more optimistic about independent film than I've been in some time. Not because distributors are suddenly throwing money around, or because the challenges facing our industry have disappeared, but because I saw something I haven't seen nearly enough of in recent years: buyers showing genuine interest in a broader range of movies.


At S&R, I had more than 30 North American distribution meetings, including conversations with Paramount, Sony, Netflix, Radial Entertainment, Vertical, Magenta Light, Saban, Brainstorm, and many others. Meanwhile, my partner, Jordan Rosner, wreslted an extensive schedule of meetings with international distributors. Between us, we had a pretty comprehensive look at what the market was thinking.


I was presenting four new films to North American buyers, and the response was remarkable. Every buyer requested feature-length screeners for all four titles, with one exception: a buyer who requested three. I've never experienced a screener-request rate approaching this level.


Of course, a screener request isn't an offer, much less a sale. These films probably won't close domestically for another two or three months, and there's plenty of work between initial interest and a signed agreement. But the breadth of that interest was encouraging, particularly because it extended beyond the genres buyers have traditionally considered safest.


One of those films is a drama we expected would be difficult to sell. Before AFM, it had been struggling to generate meaningful interest. But sitting across from buyers, explaining how audiences responded at festivals and communicating what makes the film commercially compelling, changed the conversation.


That experience reinforced something I think our industry occasionally forgets: a great movie still needs somebody who knows how to sell it. And increasingly, the quality of the movie itself may be opening doors that traditional packaging would have kept closed.


Horror Is Still Valuable. Ordinary Horror Is Getting Expensive to Sell.

Over the past several years, independent horror has produced some extraordinary commercial successes. Naturally, producers have paid attention. Horror has long been one of the more dependable independent genres, particularly because it can deliver substantial audience appeal without the production costs associated with large-scale action or science fiction.


But success attracts competition, and competition eventually changes pricing. What we heard and observed at AFM suggests we're now dealing with the consequences of too many horror films chasing buyers who have become considerably more selective.


That doesn't mean horror is dead, or even that it's no longer one of the safest genres to produce. It means a reasonably good horror movie with a familiar premise and recognizable genre cast is no longer automatically a compelling acquisition.


We're also seeing certain actors become overexposed within the genre. When audiences and distributors encounter the same names across a steady stream of similar productions, the commercial advantage those actors once provided begins to diminish.


This is particularly dangerous for producers who financed their films using sales expectations established two or three years ago. A package that once looked comfortably financeable may now be carrying a production budget that the current market simply cannot justify.


Meanwhile, something rather unexpected is happening elsewhere in the market. The lower-budget films that have spent the past several years adapting to reduced acquisition values are beginning to see some improvement, while larger independent packages that seemed relatively insulated from the downturn are finally starting to feel the pressure.


And increasingly, the difference between the films finding opportunities and those struggling to attract meaningful offers comes down to something deceptively simple: whether the finished movie is actually any good.


The Rules Go Out the Window When You Make a Great Movie

Three weeks before AFM, I participated in a sales and distribution panel at FilmQuest alongside representatives from Saban, Bleecker Street, and CAA. Throughout the discussion, we explained the familiar commercial rules: which genres travel, why recognizable cast matters, how budgets affect distribution prospects, and what makes a package attractive to buyers.


Toward the end, Steve Brake from Saban made an observation that was both funny and remarkably accurate. He essentially pointed out that all the rules we'd spent the panel explaining can go out the window when somebody makes a genuinely great movie.


I would add that the opposite is equally true.


I know of a genre film featuring a bona fide, longtime celebrity—an actor whose name would ordinarily give a producer considerable confidence in the package. Unfortunately, the finished film isn't very good, and buyers are reluctant to pay meaningful money for it. The filmmakers now face the possibility of recovering far less than the production budget was designed to support.


Five or ten years ago, a recognizable star of this level would provide considerably more protection against a disappointing finished product. Today, that protection appears less dependable. Cast still matters enormously, and two equally good films will generally benefit differently if one has a recognizable star, but buyers are increasingly unwilling to overlook weak execution simply because the poster has a familiar face.


The encouraging side of this shift is that an exceptional film without major stars may now have a better chance of finding distribution than it did even a year or two ago.


The financial implications, however, go well beyond which movies buyers are willing to watch. They affect how much producers should spend on talent, which genres still justify their budgets, and how much of a film's production cost can realistically be recovered through minimum guarantees.


🔓 PREMIUM SUBSCRIBER CONTENT

The most interesting development coming out of AFM isn't simply that buyers appear more receptive to great movies. It's that the acquisition market may be experiencing a reversal: smaller productions that adapted to the industry's new economics are beginning to recover, while larger packages that seemed almost immune to the downturn are finally showing cracks.


For producers and financiers, understanding where those pressures are appearing could fundamentally change how the next film should be packaged and budgeted.


Continue reading to learn:

  • The horror MG correction: Where we're seeing domestic acquisition values fall by 50% or more—and why certain recognizable actors are losing their commercial leverage.

  • The acquisition market's surprising reversal: Why lower-budget films are beginning to recover while larger independent packages are only now feeling the pressure.

  • The new casting opportunity: How emerging streaming talent may offer a better balance of recognition, cost, and commercial potential.

  • The budget-coverage advantage: Why the percentage of production costs covered by MGs may matter more than the size of the guarantee itself.

  • How to package for today's buyers: Which decisions can improve acquisition prospects without inflating the budget.


These observations come from S&R's active sales business and firsthand conversations with domestic and international buyers at AFM.


Before financing your next movie around an established genre, familiar actor, or historical sales estimate, understand what buyers are actually valuing today.

Want to read more?

Subscribe to snrfilms.com to keep reading this exclusive post.

 
 
 

Recent Posts

See All

Be the first to know! 
Sign up to receive special screening invites & new release updates.

Thanks for subscribing!

Copyright 2025, Scatena & Rosner Media LLC

bottom of page